Matthew Donley
Chief Operating Officer at AURINIA PHARMACEUTICALS INC.
Net worth: 3 M $ as of 2024-04-29
Network origin in Matthew Donley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
77
| Subsidiary | Biotechnology | 77 |
| Public Company | Biotechnology | 33 | |
| Subsidiary | Pharmaceuticals: Major | 29 | |
| Private Company | Specialty Stores | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthew Donley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Private Equity Investor Founder President Private Equity Investor Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Chairman President Director of Finance/CFO Public Communications Contact | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | General Counsel Chairman Public Communications Contact General Counsel | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman | |
| University of Alberta | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Iowa | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| West Virginia University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal General Counsel | |
| VIELA BIO, INC. | Biotechnology | President Chief Executive Officer Director/Board Member | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Director/Board Member Graduate Degree Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| XENCOR, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Sales & Marketing | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Public Communications Contact General Counsel Chief Tech/Sci/R&D Officer | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Founder | |
| TESARO INC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chairman Chairman | |
The United Way of the Lower Mainland
 The United Way of the Lower Mainland Investment Trusts/Mutual FundsMiscellaneous The United Way of the Lower Mainland is a non-profit organization based in Burnaby, CA. The non-profit company provides planning guides and resources to help coordinate successful United Way BC campaigns. The organization serves over 4 million British Columbians with a focus on supporting kids & youth, seniors, poverty, mental health, and food security. The Canadian company's mission is to support healthy, caring, and inclusive communities by strengthening vital connections that support people in need. | Investment Trusts/Mutual Funds | President Corporate Officer/Principal | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 41 |
| Canada | 7 |
| United Kingdom | 4 |
| Switzerland | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 2 |
| Process Industries | 2 |
Operational
| Director/Board Member | 476 |
| Corporate Officer/Principal | 241 |
| Independent Dir/Board Member | 152 |
| President | 89 |
| Chairman | 89 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| John Johnson | 40 |
| Timothy Walbert | 40 |
| James Cavanaugh | 38 |
| Peter Greenleaf | 31 |
| Robert Spiegel | 30 |
| Karen Smith | 29 |
| Michael Hayden | 27 |
| Paul Edick | 27 |
| R. MacKay-Dunn | 26 |
| Peter Kiener | 25 |
| George Milne | 24 |
| Maureen O'Connell | 24 |
| Melvin Booth | 23 |
| Wayne T. Hockmeyer | 22 |
- Stock Market
- Insiders
- Matthew Donley
- Company connections
